Eastern 0 7 0 7 B-clinical_variable
Cooperative 8 19 8 19 I-clinical_variable
Oncology 20 28 20 28 I-clinical_variable
Group 29 34 29 34 I-clinical_variable
( 35 36 35 36 I-clinical_variable
ECOG 36 40 36 40 I-clinical_variable
) 40 41 40 41 I-clinical_variable
performance 42 53 42 53 I-clinical_variable
status 54 60 54 60 I-clinical_variable
0 61 62 61 62 B-lower_bound
to 63 65 63 65 O
1 66 67 66 67 B-upper_bound

Evidence 0 8 68 76 O
of 9 11 77 79 O
active 12 18 80 86 O
, 18 19 86 87 O
noninfectious 20 33 88 101 B-chronic_disease
pneumonitis 34 45 102 113 I-chronic_disease
or 46 48 114 116 O
history 49 56 117 124 O
of 57 59 125 127 O
interstitial 60 72 128 140 B-chronic_disease
lung 73 77 141 145 I-chronic_disease
disease 78 85 146 153 I-chronic_disease

Evidence 0 8 154 162 O
of 9 11 163 165 O
hepatitis 12 21 166 175 B-chronic_disease
B 22 23 176 177 I-chronic_disease
virus 24 29 178 183 I-chronic_disease
or 30 32 184 186 O
hepatitis 33 42 187 196 B-chronic_disease
C 43 44 197 198 I-chronic_disease
virus 45 50 199 204 I-chronic_disease
infection 51 60 205 214 B-chronic_disease
or 61 63 215 217 O
risk 64 68 218 222 O
of 69 71 223 225 O
reactivation 72 84 226 238 O

Has 0 3 239 242 O
not 4 7 243 246 O
recovered 8 17 247 256 O
to 18 20 257 259 O
â‰¤ 21 22 260 261 O
Grade 23 28 262 267 B-upper_bound
1 29 30 268 269 I-upper_bound
from 31 35 270 274 O
toxic 36 41 275 280 O
effects 42 49 281 288 O
of 50 52 289 291 O
prior 53 58 292 297 B-treatment
therapy 59 66 298 305 I-treatment

Known 0 5 306 311 O
active 6 12 312 318 O
central 13 20 319 326 B-cancer
nervous 21 28 327 334 I-cancer
system 29 35 335 341 I-cancer
metastases 36 46 342 352 I-cancer
and/or 47 53 353 359 O
carcinomatous 54 67 360 373 B-cancer
meningitis 68 78 374 384 I-cancer

Locally 0 7 385 392 O
advanced 8 16 393 401 O
or 17 19 402 404 O
metastatic 20 30 405 415 B-cancer
disease 31 38 416 423 I-cancer

Prior 0 5 424 429 O
treatment 6 15 430 439 O
with 16 20 440 444 O
any 21 24 445 448 O
tumor 25 30 449 454 B-treatment
necrosis 31 39 455 463 I-treatment
factor 40 46 464 470 O
super 47 52 471 476 O
family 53 59 477 483 O
agonist 60 67 484 491 O

Receipt 0 7 492 499 O
of 8 10 500 502 O
anticancer 11 21 503 513 B-treatment
medications 22 33 514 525 I-treatment
or 34 36 526 528 O
investigational 37 52 529 544 B-treatment
drugs 53 58 545 550 I-treatment
within 59 65 551 557 O
protocol 66 74 558 566 O
- 74 75 566 567 O
defined 75 82 567 574 O
intervals 83 92 575 584 O
before 93 99 585 591 O
the 100 103 592 595 O
first 104 109 596 601 O
administration 110 124 602 616 O
of 125 127 617 619 O
study 128 133 620 625 O
drug 134 138 626 630 O

